Pricing
Not listed
Official monthly price not confirmed
- API
- Not confirmed
Exin Therapeutics
● Identity checkedAssistant · Vendor site 2026-10-04
Exin Therapeutics is building a multimodal AI discovery platform for neurotherapeutics that predicts drug candidates across neural circuit disorders. The company positions its approach as modality-agnostic, multi-target, and localized without dependence on a single genetic background.
- Category
- Assistant
- Free access
- Not confirmed
- API access
- Not confirmed
Is Exin Therapeutics right for you?
A good fit for
Drug discovery and neuroscience teams exploring AI-guided neurotherapeutic target discovery partnerships with Exin.
Before you choose
The public Google Sites page is informational only and routes contact to founders@exintherapeutics.com without product pricing.
Neurotherapeutic discovery
Exin Therapeutics combines multimodal AI with circuit-level framing to discover localized, multi-target neurotherapeutic candidates.
What it can do
Features & capabilities
Unknown is different from unavailable. Each fact carries its own evidence.
| Capability | Value | Evidence | Checked |
|---|---|---|---|
| Discovery focus | Homepage headline describes an AI discovery platform for neurotherapeutics targeting neural circuits. | Facts sourced | 2026-10-04 |
| Multimodal AI | Site copy states multimodal AI predicts drug candidate potential across multiple neural disorders simultaneously. | Facts sourced | 2026-10-04 |
| Modality agnostic | Marketing notes the platform is agnostic to therapeutic modality and genetic background. | Facts sourced | 2026-10-04 |
Understand the total cost
Exin Therapeutics pricing & plans
Alternatives to Exin Therapeutics
View all ↗
Depth - AI Product ManagerDepth is an AI product analytics platform with session replay, funnels, retention, and product-management workflows. It offers tiered session tracking for startups through enterprise, with integrations to tools like Linear and Jira on higher plans.
Explore tool
economize.cloudEconomize Cloud is a multi-cloud FinOps platform for AWS, Azure, and GCP cost visibility and optimization. Teams connect billing exports, explore spend, receive recommendations, monitor incidents, and track commitments while the company notes its acquisition by OpenMetal on the live marketing site.
Explore tool
CiteMeCiteMe is a free citation generator and reference checker that searches OpenAlex, CrossRef, PubMed, and other scholarly indexes across sixty-plus curated styles. Pro upgrades add batch PDF import, unlimited reference checking, ten-thousand-plus CSL styles, and bibliography exports without ads.
Explore toolThe practical questions
Frequently asked questions
What is Exin Therapeutics used for?
Exin Therapeutics is building a multimodal AI discovery platform for neurotherapeutics that predicts drug candidates across neural circuit disorders. The company positions its approach as modality-agnostic, multi-target, and localized without dependence on a single genetic background.
Does Exin Therapeutics have a free plan?
Not confirmed. This record does not confirm an ongoing free plan.
How much does Exin Therapeutics cost?
A listed monthly price has not been confirmed. See the plan cards for entitlements, billing commitments and seat minimums.
Can I use Exin Therapeutics through an API?
Not confirmed. API access and subscription access may have different terms; consult the linked sources.
What should I check before choosing it?
The public Google Sites page is informational only and routes contact to founders@exintherapeutics.com without product pricing.
Price history
No retained pricing changes yet. A current price alone does not establish a historical trend.
How this profile is supported
Identity and profile
Reviewed vendor source
Read original source ↗Facts apply to the named version and check date. Send a sourced correction if something changed.